Retinal cell type‐specific prevention of ischemia‐induced damages by LPS‐TLR 4 signaling through microglia
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Reprogramming of toll‐like receptor 4 (TLR 4) by brief ischemia or lipopolysacharide (LPS) contributes to superintending tolerance against destructive ischemia in brain. However, beneficial roles of TLR 4 signaling in ischemic retina are not well known. This study demonstrated that preconditioning with LPS 48 h prior to the retinal ischemia prevents the cellular damage in morphology with hematoxylin and eosin (H&E) staining and functions of retina with electroretinogram (ERG), while post‐ischemia treatment deteriorated it. The preventive effects of LPS preconditioning showed the cell type‐specificity of retinal cells. There was complete rescue of ganglion cells, partial rescue of bipolar and photoreceptor cells or no rescue of amacrine cells, respectively. LPS treatment caused the proliferation and migration of retinal microglia and its preconditioning prevented the ischemia‐induced microglial activation. Preventive actions from cell damages following LPS preconditioning prior to retinal ischemia were abolished in TLR 4 knock‐out mice, and by pre‐treatments with anti‐TLR 4 antibody or minocycline, a microglia inhibitor, which themselves had no effects on the retinal ischemia‐induced damages or microglia activation. Thus, this study revealed that TLR 4 mediates the LPS preconditioning‐induced preventive effects through microglial activation in the retinal ischemia model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596 · cited 2×
“Ischemia in the central nervous system including retina is one of the most well-known pathophysiological condition, which leads to extensive neuronal damages and functional disorders by triggering diverse types of self-reinforcing destructive mechanisms, such as necrosis and apoptosis (Lipton 1999; Bernstein et al. 20…”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“Minocycline induces protective action against several types of neurological and retinal diseases as well as ischemic damages by the inhibition of microglial activation and proliferation (Raghavendra et al. 2003; Krady et al. 2005; Zeng et al. 2005; Bye et al. 2007).”
BackgroundMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254 · cited 1×
“Similar cytotoxic effects are caused by the treatment with lipopolysaccharide (LPS), an endotoxin and known specific ligand for TLR4 (Guha and Mackman 2001; Sheng et al. 2003; Kawai and Akira 2007; Liang et al. 2007; Qin et al. 2007; Litvak et al. 2009; Jeong et al. 2010; Pang et al. 2012).”
BackgroundTikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · cited 4×
“Minocycline has emerged as a potent inhibitor of microglial activation and has no direct action on astrocytes or neurons, and its anti-inflammatory property is completely separate from its antimicrobial action (Tikka et al. 2001).”
BackgroundInfluentialMicroglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
Selective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain
Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5360-06.2007 · Cited by 874
TLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496
Chen, Z., Jalabi, W., Shpargel, K. B., Farabaugh, K. T., Dutta, R., Yin, X., Kidd, G. J., Bergmann, C. C., Stohlman, S. A., & Trapp, B. D. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0730-12.2012 · Cited by 432
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388 · cited 1×
“Similar cytotoxic effects are caused by the treatment with lipopolysaccharide (LPS), an endotoxin and known specific ligand for TLR4 (Guha and Mackman 2001; Sheng et al. 2003; Kawai and Akira 2007; Liang et al. 2007; Qin et al. 2007; Litvak et al. 2009; Jeong et al. 2010; Pang et al. 2012).”
BackgroundProliferating resident microglia after focal cerebral ischaemia in mice
Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., & Allan, S. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600495 · Cited by 342 · cited 1×
“In contrast, microglia have neuroprotective actions by producing anti-inflammatory factors including neurotrophins (Streit 2002; Denes et al. 2007; Lalancette-Hebert et al. 2007; Shpargel et al. 2008; Lambertsen et al. 2009; Ransohoff and Perry 2009; Chen et al. 2012).”
BackgroundLitvak, V., Ramsey, S. A., Rust, A. G., Zak, D. E., Kennedy, K. A., Lampano, A. E., Nykter, M., Shmulevich, I., & Aderem, A. (2009) · Nature Immunology · doi:10.1038/ni.1721 · Cited by 295
Mabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., Hori, M., & Matsumoto, M. (2000) · Stroke · doi:10.1161/01.str.31.7.1735 · Cited by 280 · cited 2×
“…by its robust change in morphology upon ischemia in brain and in retina, and subsequently causes tissue damages by releasing a multitude of noxious mediators, but minocycline reverses these effects (Mabuchi et al. 2000; Tikka et al. 2001; Lai and Todd 2006; Langmann 2007; Plane et al. 2010).”
BackgroundClinical Potential of Minocycline for Neurodegenerative Disorders
BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · cited 1×
“In animal research on neurodegenerative diseases, minocycline, a semisynthetic second-generation tetracycline, was mostly used by intraperitoneal injection and its single dosage per day ranged from 5 mg/kg to 90 mg/kg (Du et al. 2001; Blum et al. 2004).”
BackgroundMitogen-Activated Protein Kinases and Retinal Ischemia
Roth, S., Shaikh, A. R., Hennelly, M. M., Li, Q., Bindokas, V., & Graham, C. E. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0451 · Cited by 117 · cited 1×
“…in the central nervous system including retina and brain following injury/ischemia and disease conditions (Koistinaho and Koistinaho 2002; Jin et al. 2003; Ibrahim et al. 2011), though ischemia-induced expression of pp38 MAPK in other retinal cell types has also been reported (Roth et al. 2003).”
Background
Cited by
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Microglia in Retinal Degeneration
Rashid, K., Akhtar-Schaefer, I., & Langmann, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01975 · Cited by 355
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-014237 · Cited by 75
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2021) · Life · doi:10.3390/life12010033 · Cited by 15
“1 μg/mL LPS [33,34]) for 24 h or as specified, and the endothelial-barrier resistance was measured in real-time at multiple frequency modes.”
BackgroundMethod
Metadata
- Authors
- Halder, S. K., Matsunaga, H., Ishii, K. J., Akira, S., Miyake, K., & Ueda, H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2013-05-13
- Volume
- 126
- Issue
- 2
- Pages
- 243-260
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2098301688
- Cited by
- 49
- References
- 17
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.